---
title: "Ginkgo Bioworks Officer Sold Shares Worth Over $1.3M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282389846.md"
description: "Ginkgo Bioworks' CEO and Founder, Jason R. Kelly, sold shares worth over $1.3 million in two transactions on April 8 and 9, 2026, at prices of $6.93 and $6.397 per share, averaging $6.65. The sales were to cover tax obligations from the vesting of performance-based restricted stock units, with 67% vesting in April 2026. Post-sale, Kelly holds 316,483 shares of Class A Common Stock."
datetime: "2026-04-10T21:10:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282389846.md)
  - [en](https://longbridge.com/en/news/282389846.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282389846.md)
---

# Ginkgo Bioworks Officer Sold Shares Worth Over $1.3M

Jason R. Kelly, an Officer and Director (CEO & Founder), sold Class A Common Stock in two sell-to-cover transactions related to PSU vesting. The transactions occurred on 2026-04-08 and 2026-04-09 at prices of $6.93 and $6.397 per share, reflecting a weighted average price of approximately $6.65 per share. The total sale proceeds were $1,374,493. Following these transactions, the reporting person directly owns 316,483 Class A Common Stock. Each sale represented shares sold to cover tax withholding obligations in connection with the vesting of performance-based restricted stock units granted on June 19, 2025, of which 67% vested and were distributed in April 2026.

Reporter Name

Kelly Jason R

Relationship

Director

Type

Sell

Amount

$1,374,493

SEC Filing

Form 4

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [DNA.US](https://longbridge.com/en/quote/DNA.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [DNABW.US](https://longbridge.com/en/quote/DNABW.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)

## Related News & Research

- [DNA: Q2 2026 revenue dropped 48% year-over-year, with major autonomous lab contracts secured](https://longbridge.com/en/news/295007946.md)
- [Ginkgo Bioworks expands autonomous lab network to Caltech, MIT, Maryland and Northwestern](https://longbridge.com/en/news/294963724.md)
- [Medicare is about to change a drug program that held down the cost of premiums. Here's what to know.](https://longbridge.com/en/news/294391519.md)
- [Has the bull market shifted to biotech stocks?](https://longbridge.com/en/news/293077044.md)
- [HEDGE FLOW-Hedge fund bets on rising US healthcare stocks near 5-year high, Goldman says](https://longbridge.com/en/news/293938581.md)